… dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative …

S Kohsaka, T Murata, N Izumi, J Katada… - … medical research and …, 2017 - Taylor & Francis
warfarin in Japan. The objective of this study is to compare the bleeding risk among patients
… newly prescribed warfarin in Japan using a national wide administrative claim database. …

… anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data

S Kohsaka, J Katada, K Saito, A Jenkins, B Li… - Open …, 2020 - openheart.bmj.com
… of apixaban, dabigatran, edoxaban and rivaroxaban, each … the risk of ICH, stroke/SE and
major bleeding versus warfarin.… - and low-dose rivaroxaban in Asians with atrial fibrillation. J Am …

… of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data

S Kohsaka, J Katada, K Saito… - … Medical Research and …, 2018 - Taylor & Francis
… of NOACs such as apixaban, dabigatran and rivaroxaban in the real… risk of any and major
bleeding was found in the apixaban … of patients, and frequent low-dose apixaban patients were …

[HTML][HTML] Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis

Y Koretsune, T Yamashita, M Yasaka, Y Ono… - Journal of …, 2019 - Elsevier
… of dabigatran and rivaroxaban versus warfarin using data … present study, a much lower risk
associated with dabigatran … that dabigatran had a lower major bleeding rate than warfarin

Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation

YH Chan, LC See, HT Tu, YH Yeh… - Journal of the …, 2018 - Am Heart Assoc
… Baseline covariates were referred to any claim record with the … with a lower risk of major
bleeding than rivaroxaban. … Our findings in ≈88% of patients taking lowdose dabigatran in …

Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation

YH Chan, CT Kuo, YH Yeh, SH Chang, LS Wu… - Journal of the American …, 2016 - jacc.org
… the NOACs dabigatran and rivaroxaban versus warfarin in a … In contrast, our analyses
indicated that low-dose NOACs can … GI bleeding than dabigatran (n = 20,963) and apixaban (n = …

[HTML][HTML] Direct comparison of low-dose dabigatran and rivaroxaban for effectiveness and safety in patients with non-valvular atrial fibrillation

SW Meng, TT Lin, MT Liao, HM Chen… - Acta Cardiologica …, 2019 - ncbi.nlm.nih.gov
… -inferiority of low-dose rivaroxaban compared with warfarin was … incidence of gastrointestinal
hemorrhage in our rivaroxaban cohort. … Third, our study did not include apixaban. Although …

[HTML][HTML] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis

WJ Li, P Archontakis-Barakakis… - World Journal of …, 2021 - ncbi.nlm.nih.gov
hemorrhage than warfarin, while rivaroxaban and apixaban … had 30% lower risk for major
bleeding events occurrence … Management of newly detected atrial fibrillation: a clinical practice …

[HTML][HTML] … after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database

K Miyamoto, S Murata, M Takegami, K Nakajima… - IJC Heart & …, 2023 - Elsevier
… similar rate of bleeding events in patients with non-valvular AF and have replaced … patients
in the NOACs group were prescribed dabigatran (N = 581), rivaroxaban (N = 923), apixaban

… and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation―A Retrospective Chart Review Study …

Y Koretsune, H Hoshino, Y Matsuo, T Ibuki… - Circulation …, 2022 - jstage.jst.go.jp
claims data from acute care hospitals in Japan. Although … ; were taking warfarin, apixaban,
dabigatran, rivaroxaban, or … on the index date; had major bleeding, stroke/SE, or transient …